Navigation Links
Drug-Eluting Stents Safe After Heart Attack
Date:3/30/2008

Long-term study indicates they lower restenosis risk and don't increase mortality probability

SUNDAY, March 30 (HealthDay News) -- Drug-eluting stents, the small tubing placed in diseased coronary arteries to keep them open, are more effective than bare-metal stents for heart attack patients, new research shows.

In the largest study yet comparing the long-term effect of drug-eluting stents -- the drug in question retards the growth of arterial cells -- with drug-free ones, Boston researchers report the drug-eluting device lowers the risk of blood vessels narrowing again and doesn't heighten the risk of mortality.

In analyzing data from 7,216 Massachusetts patients who had stents implanted after having suffered a heart attack known as a myocardial infarction (MI), the researchers concluded that those patients who had drug-eluting stents had a 5 percent better chance of the diseased artery remaining open.

Additionally, they found, those who had an MI and got drug-eluting stents were 1.5 percent less likely than patients with bare-metal stents to have another heart attack in the two-year period that was studied. Mortality was 2.8 percent less likely in patients with drug-eluting stents, the researchers said.

The findings follow earlier smaller studies this year that showed the drug-eluting stents may be safe for MI patients but questioned their long-term effectiveness.

The new research was to be presented Sunday at a joint meeting of the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology in Chicago.

"This study confirms that the same benefits that drug-eluting stents offer other patients in preventing restenosis [re-narrowing] of the coronary arteries are still there for patients with MI, and there doesn't appear to be any trade-off in increased risk of repeat MI or death," Dr. Laura Mauri, the study's lead researcher, said in a prepared statement.

"I would feel comfortable considering drug-eluting stents on the basis of these results -- with the caveats that treated patients must be able to take antiplatelet therapy and that we definitely want to see even longer-term follow-up," added Mauri, who is chief scientific officer at the Harvard Clinical Research Institute, as well as a Brigham and Womens Hospital cardiologist and an assistant professor of medicine at Harvard Medical School.

More information

The U.S. government has more information on how stenting works.



-- Barry Hoffman



SOURCE: American College of Cardiology and Society for Cardiovascular Angiography and Interventions, news release, March 30, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
2. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
3. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
4. New Drug Shows Promise in Use With Coronary Stents
5. Experts Offer Clarity on Confusion Surrounding Stents
6. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
7. Study Finds Both Coated Stents Perform the Same
8. Stents Slightly Better Than Bypass for Blocked Left Coronary Artery
9. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
10. Surgery Better Than Stents for Multiple Blockages
11. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug-Eluting Stents Safe After Heart Attack
(Date:6/26/2017)... ... June 26, 2017 , ... ... recent review of government data released by the United Soybean Board. , ... Maryland’s soybean farmers have increased their productivity on less land per bushel, the ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... New patients ... from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a trusted ... of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, ...
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... ... Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients ... and weekends so that visits to the dentist fit into their patients’ busy ...
(Date:6/23/2017)... ... 2017 , ... By scoring 100% for fiscal management and accountability, the Arthritis ... charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. , ... Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ” ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... 26, 2017  Endo International plc (NASDAQ: ENDP ... CEO, will represent the Company in a fireside chat at ... Tuesday, June 13, 2017 at 10:40 a.m. PT / 1:40 ... in Rancho Palos Verdes, CA. ... will be available on the Company,s website at http://www.endo.com/investors/overview ...
(Date:5/23/2017)... Calif. , May 23, 2017  Leaf ... most innovative medical devices for pressure ulcer prevention, ... the American Association of Critical Care Nurses, National ... May 22-25. The Leaf Patient Monitoring ... specifically for the hospital environment.  The system seamlessly ...
(Date:5/18/2017)... May 18, 2017  Two Bayer U.S. Pharmaceutical leaders ... during its recent 28 th Woman of ... event showcases HBA,s longstanding mission of furthering the advancement ... Cindy Powell-Steffen , senior director of ... division, and Libby Howe , a regional business ...
Breaking Medicine Technology: